-       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €890EUR$1,000USD£783GBP 
      €1112EUR$1,250USD£979GBP 
            -       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €890EUR$1,000USD£783GBP 
      €1112EUR$1,250USD£979GBP 
            -       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €890EUR$1,000USD£783GBP 
      €1112EUR$1,250USD£979GBP 
            -       Clinical Trials 
- April 2025
-  40 Pages 
- Global 
   From       €890EUR$1,000USD£783GBP 
      €1112EUR$1,250USD£979GBP 
          -       Report 
- July 2025
- Global 
   From       €4360EUR$4,900USD£3,838GBP 
           -       Report 
- June 2025
- Global 
   From       €4360EUR$4,900USD£3,838GBP 
          -       Report 
- July 2025
-  175 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
            -       Report 
- August 2025
-  146 Pages 
- Global 
   From       €2268EUR$2,549USD£1,997GBP 
      €2669EUR$2,999USD£2,349GBP 
            -       Report 
- May 2025
-  150 Pages 
- Global 
   From       €2268EUR$2,549USD£1,997GBP 
      €2669EUR$2,999USD£2,349GBP 
          -       Report 
- January 2025
-  180 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
            -       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €890EUR$1,000USD£783GBP 
      €1112EUR$1,250USD£979GBP 
          -       Report 
- July 2025
-  208 Pages 
- Global 
   From       €2225EUR$2,500USD£1,958GBP 
            -       Report 
- November 2024
-  150 Pages 
- Global 
   From       €3426EUR$3,850USD£3,016GBP 
      €4316EUR$4,850USD£3,799GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- June 2025
-  150 Pages 
- Global 
   From       €2402EUR$2,699USD£2,114GBP 
          -       Report 
- June 2025
-  200 Pages 
- Global 
   From       €2482EUR$2,789USD£2,185GBP 
          -       Report 
- June 2025
-  150 Pages 
- Global 
   From       €2402EUR$2,699USD£2,114GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- September 2025
-  89 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
       
      Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for    longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less   Read more